In humans, the GPR151 p.Arg95Ter LOF variant is associated with reduced BMI and WHRadjBMI, lower risk of T2D, improved lipid profile and a directionally consistent reduction of fasting glucose and insulin. This evidence concerns the gene INS and type 2 diabetes mellitus.